改变喘的过程:临床缓解的机制和策略
Benedetta Bondi1,2, Diego Bagnasco1,2, Fulvio Braido1,2
1Respiratory and Allergy Clinic, IRCCS Ospedale Policlinico San Martino.
Current opinion in allergy and clinical immunology
|December 2, 2025
概括
通过生物疗法和改变生活方式,现在可以实现喘的临床缓解. 综合这些因素的多维方法是长期疾病控制的关键.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘管理正在从症状控制转向临床缓解.
- 生物疗法和更好地了解疾病机制使得缓解是可以实现的.
- 综合临床,功能和生物结果,可以全面了解长期控制喘.
研究的目的:
- 审查目前的临床缓解状态作为喘管理的目标.
- 讨论生物疗法,精准医学和免疫病理学在实现喘缓解中的作用.
- 突出评估长期疾病控制的综合框架的重要性.
主要方法:
- 对生物药物及其在实现喘缓解方面的有效性最近证据的审查.
- 对改变生活方式,早期干预和过敏原免疫疗法进行分析,以提高缓解率.
- 基于不同定义的缓解率和可变性的真实数据的检查.
主要成果:
- 生物药物 (Mepolizumab,Omalizumab,Dupilumab,Benralizumab,Tezepelumab) 可以诱导严重喘的临床缓解,特别是T2-高的表型.
- 生活方式的改变 (减肥,戒烟),早期治疗和过敏原免疫疗法可以改善缓解的机会.
- 缓解率因缺乏普遍接受的定义而有很大差异,需要标准化的标准.
结论:
- 临床缓解是喘管理的一个可行的目标.
- 涉及生物药物,早期干预,并发症管理和生活方式改变的多维战略至关重要.
- 标准化定义和生物标志物对于指导治疗和预测结果至关重要.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:26Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K